Arcadia Biosciences (RKDA) Competitors $3.86 -0.33 (-7.88%) (As of 11/14/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends RKDA vs. EVGN, SEED, NCRA, AGFY, CEAD, SANW, IVP, SISI, YTEN, and EDBLShould you be buying Arcadia Biosciences stock or one of its competitors? The main competitors of Arcadia Biosciences include Evogene (EVGN), Origin Agritech (SEED), Nocera (NCRA), Agrify (AGFY), CEA Industries (CEAD), S&W Seed (SANW), Inspire Veterinary Partners (IVP), Shineco (SISI), Yield10 Bioscience (YTEN), and Edible Garden (EDBL). Arcadia Biosciences vs. Evogene Origin Agritech Nocera Agrify CEA Industries S&W Seed Inspire Veterinary Partners Shineco Yield10 Bioscience Edible Garden Arcadia Biosciences (NASDAQ:RKDA) and Evogene (NASDAQ:EVGN) are both small-cap basic materials companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, profitability, community ranking, risk, analyst recommendations, valuation, earnings and institutional ownership. Do analysts prefer RKDA or EVGN? Arcadia Biosciences presently has a consensus target price of $6.00, suggesting a potential upside of 55.44%. Evogene has a consensus target price of $12.00, suggesting a potential upside of 585.71%. Given Evogene's higher probable upside, analysts plainly believe Evogene is more favorable than Arcadia Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Arcadia Biosciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50Evogene 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals & insiders have more ownership in RKDA or EVGN? 17.7% of Arcadia Biosciences shares are owned by institutional investors. Comparatively, 10.4% of Evogene shares are owned by institutional investors. 1.8% of Arcadia Biosciences shares are owned by company insiders. Comparatively, 7.4% of Evogene shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community prefer RKDA or EVGN? Arcadia Biosciences received 66 more outperform votes than Evogene when rated by MarketBeat users. However, 56.27% of users gave Evogene an outperform vote while only 55.53% of users gave Arcadia Biosciences an outperform vote. CompanyUnderperformOutperformArcadia BiosciencesOutperform Votes28655.53% Underperform Votes22944.47% EvogeneOutperform Votes22056.27% Underperform Votes17143.73% Does the media favor RKDA or EVGN? In the previous week, Arcadia Biosciences had 3 more articles in the media than Evogene. MarketBeat recorded 7 mentions for Arcadia Biosciences and 4 mentions for Evogene. Evogene's average media sentiment score of 0.57 beat Arcadia Biosciences' score of 0.01 indicating that Evogene is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Arcadia Biosciences 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Evogene 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is RKDA or EVGN more profitable? Arcadia Biosciences has a net margin of -110.61% compared to Evogene's net margin of -210.26%. Arcadia Biosciences' return on equity of -52.63% beat Evogene's return on equity.Company Net Margins Return on Equity Return on Assets Arcadia Biosciences-110.61% -52.63% -34.57% Evogene -210.26%-72.33%-40.42% Which has more volatility & risk, RKDA or EVGN? Arcadia Biosciences has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500. Comparatively, Evogene has a beta of 1.43, suggesting that its share price is 43% more volatile than the S&P 500. Which has preferable valuation and earnings, RKDA or EVGN? Arcadia Biosciences has higher earnings, but lower revenue than Evogene. Arcadia Biosciences is trading at a lower price-to-earnings ratio than Evogene, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioArcadia Biosciences$5.33M0.98-$13.98M-$4.28-0.90Evogene$5.64M1.67-$23.88M-$3.96-0.44 SummaryArcadia Biosciences and Evogene tied by winning 9 of the 18 factors compared between the two stocks. Ad Paradigm Press[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000! And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet. And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO.Click here now for the urgent details on this hidden play. Get Arcadia Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RKDA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RKDA vs. The Competition Export to ExcelMetricArcadia BiosciencesAgricultural production IndustryMaterials SectorNASDAQ ExchangeMarket Cap$5.25M$1.99B$2.83B$8.98BDividend YieldN/A2.57%5.28%4.05%P/E Ratio-0.9011.34108.9313.56Price / Sales0.981.66591,750.6589.50Price / CashN/A51.3923.4036.41Price / Book0.521.303.626.01Net Income-$13.98M$1.02M$146.94M$225.40M7 Day Performance-4.69%-3.71%-3.32%-1.15%1 Month Performance36.88%-11.13%-3.23%3.62%1 Year Performance25.32%-12.11%25.48%24.95% Arcadia Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RKDAArcadia Biosciences2.6504 of 5 stars$3.86-7.9%$6.00+55.4%+20.2%$5.25M$5.33M-0.9060Analyst ForecastShort Interest ↑Gap DownEVGNEvogene3.0814 of 5 stars$1.92-2.0%N/A-72.3%$10.31M$5.64M-0.48140Upcoming EarningsShort Interest ↓SEEDOrigin AgritechN/A$2.71+6.3%N/A+20.4%$17.18M$13M0.0063News CoverageNCRANocera0.8378 of 5 stars$1.04+1.0%N/A-32.4%$14.38M$23.92M-2.7410Short Interest ↓Positive NewsAGFYAgrify0.6112 of 5 stars$7.60-0.8%N/A-46.3%$10.11M$16.87M-0.48140Short Interest ↑News CoverageCEADCEA Industries1.1308 of 5 stars$6.60-1.2%N/A+15.8%$5.21M$6.91M-1.4330Short Interest ↓News CoverageSANWS&W Seed1.16 of 5 stars$2.25+3.7%N/A-82.4%$5.13M$60.44M-0.17180Short Interest ↑IVPInspire Veterinary Partners0.0807 of 5 stars$0.24-3.6%N/A-99.5%$4.56M$16.67M0.00156Short Interest ↑Gap DownSISIShineco0.8193 of 5 stars$2.64-12.3%N/A-89.0%$3.72M$9.80M0.0070Stock SplitShort Interest ↓News CoverageHigh Trading VolumeYTENYield10 BioscienceN/A$0.45+12.5%N/A-93.5%$302,000.00$60,000.00-0.0230Gap UpEDBLEdible Garden0.2117 of 5 stars$0.16-10.6%N/A-98.5%$85,000.00$14.05M0.0050Short Interest ↑News CoverageGap UpHigh Trading Volume Related Companies and Tools Related Companies EVGN Competitors SEED Competitors NCRA Competitors AGFY Competitors CEAD Competitors SANW Competitors IVP Competitors SISI Competitors YTEN Competitors EDBL Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:RKDA) was last updated on 11/15/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your fi...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcadia Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arcadia Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RKDA Stock Alerts